OmniAb (OABI) Retained Earnings (2021 - 2026)
OmniAb (OABI) posted quarterly Retained Earnings of -$173.9 million for Q1 2026, down 144.23% year-over-year from $393.1 million in Q1 2025, and down 1449150.0% quarter-over-quarter from $12000.0 in Q4 2025.
OmniAb (OABI) Retained Earnings (2021 - 2026) Analysis & Trends
OmniAb (OABI) has reported Retained Earnings for 6 consecutive years, with -$173.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 144.23% year-over-year to -$173.9 million; the TTM figure through Mar 2026 stood at -$173.9 million (down 144.23% YoY), while the FY2025 annual figure was $12000.0, up 100.01% from the prior year.
- Retained Earnings slipped to -$173.9 million in Q1 2026 per OABI's latest filing, from $12000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $393.1 million in Q1 2025 and bottomed at -$173.9 million in Q1 2026.
- Historically, Retained Earnings has averaged $36.5 million across 5 years, with a median of -$49000.0 in 2023.
- Annual changes were most pronounced in 2023 — Retained Earnings jumped 3932011.11% — and 2024, when it plunged 180169.39%.
- OmniAb's Retained Earnings stood at $9000.0 in 2022, then surged by 3932011.11% to $353.9 million in 2023, then sank by 128.65% to -$101.4 million in 2024, then surged by 100.01% to $12000.0 in 2025, then sank by 1449150.0% to -$173.9 million in 2026.
- Business Quant data shows OABI's Retained Earnings at -$173.9 million in Q1 2026, $12000.0 in Q4 2025, and $5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | OmniAb | 491.42 Mn | 439.42 Mn | 12.81 Mn | 440.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 440.02 Mn |
| Mar 31, 2026 | -173.89 Mn |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | 393.10 Mn |
| Dec 31, 2024 | -101.40 Mn |
| Sep 30, 2024 | -88.33 Mn |
| Jun 30, 2024 | -25,000.00 |
| Mar 31, 2024 | -58.33 Mn |
| Dec 31, 2023 | 353.89 Mn |
| Sep 30, 2023 | -49,000.00 |
| Jun 30, 2023 | -49,000.00 |
| Mar 31, 2023 | 335.63 Mn |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | -13.87 Mn |
| Jun 30, 2022 | -14.34 Mn |
| Mar 31, 2022 | -12.36 Mn |
| Sep 30, 2021 | -6.90 Mn |
| Jun 30, 2021 | 24,425.00 |